215 related articles for article (PubMed ID: 24001379)
1. BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded).
El-Mofty M; Mostafa W; Youssef R; El-Fangary M; El-Ramly A; Mahgoub D; Fawzy M; El-Hawary M
Photodermatol Photoimmunol Photomed; 2013 Oct; 29(5):239-46. PubMed ID: 24001379
[TBL] [Abstract][Full Text] [Related]
2. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial.
El Mofty M; Bosseila M; Mashaly HM; Gawdat H; Makaly H
Clin Exp Dermatol; 2013 Dec; 38(8):830-5. PubMed ID: 23551324
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
4. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet A in vitiligo.
El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
[TBL] [Abstract][Full Text] [Related]
7. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
8. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
9. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
10. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
Verhaeghe E; Lodewick E; van Geel N; Lambert J
Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo.
El-Zawahry BM; Bassiouny DA; Sobhi RM; Abdel-Aziz E; Zaki NS; Habib DF; Shahin DM
Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):84-90. PubMed ID: 22409711
[TBL] [Abstract][Full Text] [Related]
12. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
Baldo A; Lodi G; Di Caterino P; Monfrecola G
G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
[TBL] [Abstract][Full Text] [Related]
14. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
15. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
[TBL] [Abstract][Full Text] [Related]
17. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
El Mofty M; Mostafa W; Esmat S; Youssef R; Azzam O; Hunter N; El Hanafi G; Fawzi M
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
[TBL] [Abstract][Full Text] [Related]
18. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
20. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
